Do menopause supplements work? What the evidence actually shows

The menopause supplement market is worth more than $17 billion globally and growing. That number is not evidence of efficacy — it is evidence of demand meeting weak regulation. In the United States, dietary supplements do not need FDA approval for safety or effectiveness before sale, and manufacturers are not required to prove a claimed benefit before printing it on a box.

The headline finding

Across systematic reviews, no dietary supplement has been shown to be more effective than placebo for hot flashes. Placebo response in vasomotor symptom trials is genuinely large — often 25 to 40% symptom reduction — which is why uncontrolled testimonials feel so convincing and why controlled trials matter so much.

Ingredient by ingredient

• Black cohosh — the most studied botanical for hot flashes. Results across trials are inconsistent and the better-designed studies are largely negative. Rare reports of hepatotoxicity mean it is not risk-free.
• Soy isoflavones and red clover — small, inconsistent effects on hot flash frequency; effect appears to depend partly on individual gut metabolism (equol producers). Not a substitute for hormone therapy in moderate-to-severe symptoms.
• Evening primrose oil — repeatedly studied, repeatedly no better than placebo for vasomotor symptoms.
• Maca, DIM, wild yam cream — no credible controlled evidence for menopausal symptom relief. Wild yam cream does not convert to progesterone in the body.
• Dong quai, ginseng, flaxseed — no consistent vasomotor benefit in controlled trials.
• Compounded or over-the-counter "estrogen boosters" and "hormone balancers" — unregulated, sometimes adulterated, and the category most likely to carry undeclared active ingredients.

The four that do have a defensible role

• Vitamin D and calcium — for bone health where dietary intake or serum levels are inadequate. Not symptom treatment; skeletal protection.
• Protein (as intake, not a pill) — 1.2 g/kg/day supports lean mass retention through a decade of accelerating sarcopenia.
• Creatine monohydrate — reasonable evidence for strength and lean mass when paired with resistance training. Cheap, well-studied, and honest about what it does.
• Magnesium glycinate — modest support for sleep quality in some patients; low risk, low cost, no cure claims.

What actually treats moderate-to-severe symptoms

Hormone therapy remains first-line for moderate-to-severe vasomotor symptoms in women under 60 or within 10 years of their final period, absent contraindications. For women who cannot or prefer not to take hormones, the evidence-based non-hormonal options are prescription medications — SSRIs and SNRIs, gabapentin, oxybutynin, and NK3-receptor antagonists such as fezolinetant — not botanicals.

That is the uncomfortable summary: the treatments that work mostly require a prescription and a clinician who understands menopause, and the treatments sold hardest require neither.

How to read a supplement claim

• Look for a placebo-controlled trial in menopausal women, not a mechanism story or a cell study.
• Check for third-party testing (USP or NSF). It verifies contents, not benefit.
• Treat "clinically studied" as marketing until you see the trial design and the comparator.
• Tell your clinician everything you take. Botanicals interact — St. John’s wort and tamoxifen being one clinically important example.

We do not sell supplements as a substitute for treatment, and our [clinical governance standards](/clinical-governance) commit us to saying so plainly even where it costs us margin.

Medically reviewed by Kindr Health Clinical Team
Kindr Health Inc. — Editorial & Clinical Team, led by Kevin Wolfe, CMO
NPI 1609792902 · Last reviewed: July 26, 2026